Keywords: gsk/s-p, levitra, effective, patients, hypertension, drugs, uk-based
GSK/S-P's Levitra 83% "effective" in patients on hypertension drugs
Article | 27 March 2006
UK-based GlaxoSmithKline, the world's second-largest drugmaker, and US drug major Schering-Plough say that their co-marketed erectile dysfunction drug Levitra (vardenafil, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- US Supreme Court says patent settlement can "sometimes" be illegal
